Long-Acting HIV Therapy Tested in African Adults With Adherence Barriers
A phase 3b trial compared injectable cabotegravir-rilpivirine with oral dolutegravir-based therapy in adults with suppressed HIV and adherence challenges.
This section contains the website’s posts.